JOHNSON & JOHNSON STOPS COVID-19 VACCINE TRIAL AFTER UNEXPLAINED ILLNESS
Drugmaker Johnson & Johnson said Monday it has paused the advanced clinical trial of its experimental coronavirus vaccine because of an unexplained illness in one of the volunteers.
In a statement, Johnson & Johnson said : “Following our guidelines, the participant’s illness is being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board (DSMB) as well as our internal clinical and safety physicians,”
Johnson & Johnson’s Janssen vaccine arm is developing the shot.
The company did not say what the unexplained illness was, but one point of clinical trials is to find out if vaccines cause dangerous side effects.
Trials are stopped when they pop up while doctors check to see if the illness can be linked to the vaccine or is a coincidence.
“Based on our strong commitment to safety, all clinical studies conducted by the Janssen Pharmaceutical Companies of Johnson & Johnson have prespecified guidelines. These ensure our studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study,” the company said.